Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Jacobi Jäckel, Herma
DOB: 25-SEP-1973 (Age: 52)
Gender: female
Address:
Jorge-Linke-Gasse 15/68
56727 Mayen (Germany)
ID: 6016-265554-6 (ECI)
Report
Date: 15-SEP-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Facharzt für Allgemeinmedizin Johann Holbach
Schulstraße 12
56753 Mertloch (Germany)
Specimen
Collected: 15-SEP-2023

Chemistry

Test 15-SEP-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 76.0 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.2 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.3 H 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.6 - 10.2 mg/dL
Sodium [Moles/volume] in Blood 140.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 108.1 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.2 22 - 32 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating impaired glucose control or prediabetes. Creatinine is slightly elevated, suggesting possible reduced kidney function. Chloride is marginally high but likely not clinically significant. Other parameters are within normal limits. Recommend clinical correlation for kidney function and glycemic status, and consider follow-up testing.